{"organizations": [], "uuid": "de1c0f5f64036737396e8dacadf8c73e4c4e47b2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/MedicalDeviceFinancing", "section_title": "Medical Device Financing from Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201230674?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d%2520(%2540industries%253d%2522Medical%2520Devices%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "US", "title": "Oculeve raises $7.6mm in Series A financing; adds $27.5k", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Oculeve raises $7.6mm in Series A financing; adds $27.5k", "spam_score": 0.0, "site_type": "news", "published": "2015-07-09T02:30:00.000+03:00", "replies_count": 0, "uuid": "de1c0f5f64036737396e8dacadf8c73e4c4e47b2"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201230674?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d%2520(%2540industries%253d%2522Medical%2520Devices%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Oculeve raises $7.6mm in Series A financing; adds $27.5k", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Oculeve raises $7.6mm in Series A financing; adds $27.5k Deal Date: Oct-01-2012 / Deal Update Date (Latest): Mar-01-2013 / Deal # 201230674 Executive Summary \nOculeve Inc. (implantable ophthalmic devices) raised $7.6mm in Series A financing from eight investors including returning shareholder Kleiner Perkins Caufield & Byers plus Versant Ventures and New Enterprise Associates. The company spun out of Stanford University in 2011 to develop an implantable nasal electrode that treats dry eye. The neurostimulation technology targets the lacrimal gland to restore tear production.", "external_links": [], "published": "2015-07-09T02:30:00.000+03:00", "crawled": "2015-07-09T16:07:23.000+03:00", "highlightTitle": ""}